Funded Health Care Startups in Brazil
Among the 32 most recent Brazil health care funding entries shown, the largest disclosed round is Bionexo’s $81M (2021-10-15).
Among the 32 most recent Brazil health care funding entries shown, the largest disclosed round is Bionexo’s $81M (2021-10-15). That figure dwarfs the rest: the next-largest disclosed amounts cluster around $20M (Mevo $20M on 2024-09-18 and Sami $20M on 2021-12-14), while the majority of other disclosed rounds sit well below that range (e.g., Clinia’s $350K on 2024-11-21 and Cyon Equipamentos’ $100K on 2021-08-10).
Geographically, the list is heavily city-concentrated in São Paulo state: 24 of 32 rows name São Paulo, Sao Paulo, Brazil, including multiple large rounds such as Memed’s $16M (2026-05-21) and Zenklub’s $8M (2021-02-10). Temporally, funding events span 2020-08-01 (Closecare) through 2026-05-21 (Memed), with a dense recent band in late 2024 (e.g., Clinia 2024-11-21 through Central da Visão 2024-11-06) and notable mid-2022 activity (Wellbe.co 2022-07-01, ISA 2022-08-10, Digital Aligner 2022-05-11). Stage labels are also mixed: 11 of 32 entries are marked “undisclosed” (including Pipo Saúde 2025-01-01; Mevo is disclosed at $20M on 2024-09-18), and “Series Unknown” appears 12 times (e.g., Vetwork 2024-09-09 at $4M).
Most recent rounds
32 shownRelated listings
Frequently asked
What’s the biggest disclosed round here, and is it an outlier compared with the rest of the amounts?
Bionexo’s $81M on 2021-10-15 is the largest disclosed amount in the table and it materially exceeds the next-largest disclosed figures, which are around $20M (Mevo $20M on 2024-09-18; Sami $20M on 2021-12-14). Multiple other disclosed rounds remain far lower, including Clinia’s $350K (2024-11-21) and Cyon Equipamentos’ $100K (2021-08-10).
Are there strong geographic clusters among these Brazil health care fundings?
Yes. São Paulo, Sao Paulo, Brazil is the dominant location with 24 of 32 rows, covering both large disclosed rounds (Memed $16M on 2026-05-21; ISA $12M on 2022-08-10) and smaller disclosed ones (Signs Health $1M on 2021-03-10). Outside São Paulo, the list includes single-country-state pockets such as Curitiba (Hilab 2022-11-16 at $12M; Wellbe.co 2022-07-01 is undisclosed).
Which parts of the timeline look most concentrated within the rows shown?
Late 2024 is relatively dense: Clinia closed 2024-11-21 ($350K) and Central da Visão closed 2024-11-06 ($2M), followed by Mevo on 2024-09-18 ($20M) and Vetwork on 2024-09-09 ($4M). The overall coverage spans from 2020-08-01 (Closecare) to 2026-05-21 (Memed), so these late-2024 entries cluster near the upper end of the window.
How should stage interpretation be handled in this dataset, given the number of missing or unknown labels?
Stage labeling is frequently non-specific: 11 of 32 entries are marked “undisclosed” for amount (e.g., Pipo Saúde on 2025-01-01; Beep Saúde on 2022-11-14), and “Series Unknown” appears 12 times (e.g., Vetwork 2024-09-09 at $4M; Bio 2023-04-03 is labeled Seed at $390K, contrasting with unknown series classifications). As a result, stage-and-size comparisons should rely on disclosed amounts when available.
What are the clearest low-end and high-end amount points to anchor expectations for disclosed funding sizes?
At the low end, the smallest disclosed amount shown is $100K for Cyon Equipamentos (2021-08-10). At the high end, Bionexo’s $81M (2021-10-15) sits far above the rest; even other large disclosed rounds such as Mevo’s $20M (2024-09-18) and Sami’s $20M (2021-12-14) are well below Bionexo.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.